I agree that this site is using cookies. You can find further informations here.
X
Muhamad, Nadda
7  results:
Articles (Online) X
Search for persons X
?
1

The pharmacokinetic differences between 10‐ and 15‐μg daily..:

You, Tao ; Muhamad, Nadda ; Jenner, Joseph.
British Journal of Clinical Pharmacology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

MyACR: A Point-of-Care Medical Device for Determination of ..:

Muhamad, Nadda ; Youngvises, Napaporn ; Plengsuriyakarn, Tullayakorn...
Diagnostics.  14 (2024)  16 - p. 1702 , 2024
Link: https://doi.org/10.3390/..
 
?
3

The roles of CYP2C19 and CYP3A4 in the in vitro metabolism ..:

Muhamad, Nadda ; Na‐Bangchang, Kesara
Pharmacology Research & Perspectives.  11 (2023)  6 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

Atractylodes lancea for cholangiocarcinoma: Modulatory effe..:

Muhamad, Nadda ; Plengsuriyakarn, Tullayakorn ; Na-Bangchang, Kesara.
PLOS ONE.  17 (2022)  11 - p. e0277614 , 2022
Link: https://doi.org/10.1371/..
 
?
5

Phase I clinical trial to evaluate the safety and pharmacok..:

Na-Bangchang, Kesara ; Kulma, Inthuorn ; Plengsuriyakarn, Tullayakorn...
Journal of Traditional and Complementary Medicine.  11 (2021)  4 - p. 343-355 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Metabolite Profiling in Anticancer Drug Development: A Syst..:

Muhamad, Nadda ; Na-Bangchang, Kesara
Drug Design, Development and Therapy.  14 (2020)  - p. 1401-1444 , 2020
Link: https://doi.org/10.2147/..
 
?
7

Application of active targeting nanoparticle delivery syste..:

Muhamad, Nadda ; Plengsuriyakarn, Tullayakorn ; Na-Bangchang, Kesara
International Journal of Nanomedicine.  13 (2018)  - p. 3921-3935 , 2018
Link: https://doi.org/10.2147/..
 
1-7